Ligand Pharmaceuticals Incorporated Cash Flow Quality Index
Ligand Pharmaceuticals Incorporated cash flow quality index. Ligand Pharmaceuticals Incorporated (LGND) has a Cash Flow Quality Index of 0.50x as of June 2026. Operating cash flow of $24.02 Million is below net income of $48.51 Million, suggesting accrual-heavy earnings not yet converted to cash. See LGND financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Ligand Pharmaceuticals Incorporated (2007–2025)
Cash flow quality index of Ligand Pharmaceuticals Incorporated from 2007 to 2025. Historical Cash Flow Quality Index for Ligand Pharmaceuticals Incorporated across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Ligand Pharmaceuticals Incorporated (LGND) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Ligand Pharmaceuticals Incorporated Cash Flow Quality Index by Year (2007–2025)
Ligand Pharmaceuticals Incorporated cash flow quality index by year from 2007 to 2025. Year-by-year earnings quality comparison for Ligand Pharmaceuticals Incorporated. For the full cash flow conversion analysis, see LGND cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | $49.36 Million | $124.45 Million | ▼ -58.3% |
| 2023 | 0.95x | $49.58 Million | $52.15 Million | ▼ -31.1% |
| 2021 | 1.38x | $78.80 Million | $57.14 Million | ▲ +3058.3% |
| 2019 | -0.05x | $-29.34 Million | $629.30 Million | ▼ -103.4% |
| 2018 | 1.35x | $194.06 Million | $143.32 Million | ▼ -81.8% |
| 2017 | 7.45x | $93.57 Million | $12.56 Million | ▲ +4452.7% |
| 2015 | 0.16x | $41.73 Million | $254.93 Million | ▼ -91.3% |
| 2014 | 1.89x | $20.57 Million | $10.89 Million | ▼ -19.4% |
| 2013 | 2.34x | $20.69 Million | $8.83 Million | ▲ +2133.4% |
| 2011 | -0.12x | $-1.17 Million | $10.17 Million | ▲ +66.8% |
| 2007 | -0.35x | $-97.73 Million | $281.69 Million | — |